Carlos Cordon-Cardo

Carlos Cordon-Cardo is a pathologist and scientist known for his contributions to the field of oncology. He is currently the Irene Heinz Given and John LaPorte Given Professor and Chair of the Department of Pathology at the Mount Sinai Health System.

Early Life and Education[edit | edit source]

Carlos Cordon-Cardo was born in Barcelona, Spain. He completed his medical and doctoral degrees at the University of Barcelona, where he specialized in Pathology and Molecular Genetics.

Career[edit | edit source]

Cordon-Cardo moved to the United States in the 1980s, where he began his research career at the Memorial Sloan Kettering Cancer Center. His work primarily focuses on the molecular mechanisms of human cancer, including the role of tumor suppressor genes and oncogenes.

In 2011, he joined the Mount Sinai Health System as the Chair of the Department of Pathology. His current research involves the use of genomics and proteomics to understand the biology of cancer and develop new diagnostic and therapeutic strategies.

Contributions to Oncology[edit | edit source]

Cordon-Cardo is known for his pioneering work in the field of oncology. He was one of the first scientists to identify the role of p53, a tumor suppressor gene, in human cancer. His research has also led to the development of new diagnostic tools and treatments for various types of cancer.

Awards and Honors[edit | edit source]

Over the course of his career, Cordon-Cardo has received numerous awards and honors for his contributions to the field of oncology. These include the American Cancer Society's Medal of Honor and the National Cancer Institute's Outstanding Investigator Award.

References[edit | edit source]

External Links[edit | edit source]

Carlos Cordon-Cardo at Mount Sinai Health System

Carlos Cordon-Cardo Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.